CSQ Bio’s collagen powder turns into a wound-covering gel. Can it win over US surgeons?
CSQ Bio has established a surgical commercialization business and introduced INNESTO Rx, a bovine collagen powder scheduled for US sales in January 2027. The product uses an existing FDA-cleared device platform, but clinical differentiation, reimbursement and distribution economics remain unproven.